My watch list
my.bionity.com  
Login  

Confo Therapeutics is a drug discovery company building a unique pipeline of GPCR targeted therapeutics addressing unmet medical need. The company was founded in 2015 as a spin-off from the Vrije Universiteit Brussel and VIB and capitalizes on the ConfoBody™ technology developed by Prof. Jan Steyaert at VIB Structural Biology Research Center, Vrije Universiteit Brussel.

More about Confo Therapeutics
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE